Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael Jacob Wagner, M.D.

Concepts (167)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hemangiosarcoma620242153.640 Why?
Sarcoma12202418061.950 Why?
Chondrosarcoma420223061.770 Why?
Sarcoma, Synovial320241561.040 Why?
Bone Neoplasms6202225650.990 Why?
Osteosarcoma420229110.960 Why?
Soft Tissue Neoplasms6202311640.920 Why?
Hemangioendothelioma120231120.820 Why?
Hemangioendothelioma, Epithelioid12023540.820 Why?
Anthracyclines220212860.780 Why?
Gastrointestinal Stromal Tumors320246170.780 Why?
Ifosfamide320242330.770 Why?
Liposarcoma220222890.690 Why?
Neoplasms, Connective and Soft Tissue12020340.690 Why?
Antineoplastic Combined Chemotherapy Protocols82024118780.680 Why?
Doxorubicin5202322340.630 Why?
Phosphatidylcholines220174060.610 Why?
Vascular Endothelial Growth Factor Receptor-2120215470.610 Why?
Leiomyosarcoma120224260.600 Why?
Receptor, EphA212017410.560 Why?
Antigens, Neoplasm2202119970.530 Why?
Neoplasms, Second Primary1202410610.520 Why?
Rare Diseases120216310.510 Why?
Vincristine1201710400.470 Why?
Protein-Tyrosine Kinases1202424330.470 Why?
MAP Kinase Signaling System1202114940.450 Why?
Liposomes120177900.420 Why?
Liposarcoma, Myxoid22024600.410 Why?
Up-Regulation1202141460.390 Why?
RNA Interference1201728320.300 Why?
Gene Expression Regulation, Neoplastic2202186470.300 Why?
RNA, Small Interfering1201734280.290 Why?
Breast Neoplasms22024212060.260 Why?
SEER Program2202214440.260 Why?
Nanoparticles1201719850.240 Why?
Phenylurea Compounds220175310.220 Why?
Retrospective Studies112024817620.210 Why?
Antineoplastic Agents52017136760.190 Why?
Sarcoma, Kaposi120243760.190 Why?
Vesicular Transport Proteins120243770.190 Why?
Humans3720247681660.180 Why?
Young Adult112024600660.180 Why?
Ubiquitin Thiolesterase120244650.180 Why?
Mesna12020620.180 Why?
Interleukin-15120211860.170 Why?
Adult1820242236460.160 Why?
Protective Agents120201500.160 Why?
Aged1520241715040.160 Why?
Adjuvants, Immunologic120249980.160 Why?
Pyrimidinones120213860.150 Why?
Antineoplastic Agents, Alkylating120226140.150 Why?
Mastectomy, Segmental120239740.150 Why?
High-Throughput Nucleotide Sequencing2202436710.150 Why?
In Situ Hybridization, Fluorescence1202425210.150 Why?
Neoplasm Recurrence, Local2202094190.150 Why?
Cell Proliferation42021104740.150 Why?
Middle Aged1520242234920.140 Why?
Ribosomal Protein S6 Kinases, 70-kDa120171030.140 Why?
Xenograft Model Antitumor Assays3202136110.140 Why?
Mice, Nude2202136230.140 Why?
Molecular Targeted Therapy3202028300.140 Why?
Male1820243647190.140 Why?
Genetic Heterogeneity120207360.140 Why?
Solitary Fibrous Tumors12017700.130 Why?
Female1820243971920.130 Why?
Thrombocytopenia1202411790.130 Why?
Receptors, Antigen, T-Cell2202325680.130 Why?
Kaplan-Meier Estimate3202265260.130 Why?
Pyridones120218190.130 Why?
Leukocytes, Mononuclear1202218540.120 Why?
Incidence22024215380.120 Why?
Retinal Vein Occlusion120161490.120 Why?
Pyridines2201728940.120 Why?
Quinazolines1202113730.120 Why?
Anemia1202415140.120 Why?
Membrane Proteins2202178760.110 Why?
Cancer Vaccines1202110410.110 Why?
Treatment Outcome92021653710.110 Why?
Tumor Cells, Cultured1202161240.110 Why?
Aged, 80 and over72024596290.100 Why?
Neoplasm Metastasis2202149120.100 Why?
Survival Analysis32021101010.100 Why?
Tissue Distribution1201723000.100 Why?
Prognosis32022300100.100 Why?
Adolescent72024891690.100 Why?
Child52024809170.100 Why?
Drug Evaluation, Preclinical1201713380.100 Why?
Proto-Oncogene Proteins1202445280.100 Why?
Developing Countries1202429100.090 Why?
Immunotherapy, Adoptive1202115120.090 Why?
Lymphocyte Activation1202155050.090 Why?
Macaca mulatta1201723630.090 Why?
Ovarian Neoplasms2201749160.080 Why?
Angiogenesis Inhibitors2201720560.080 Why?
Apoptosis3202195230.080 Why?
Neoplasm Invasiveness1201736200.080 Why?
Neoplasm Proteins1202136030.080 Why?
CD4-Positive T-Lymphocytes1202144150.080 Why?
Gastrointestinal Neoplasms120169570.080 Why?
Proto-Oncogene Proteins c-akt1201724570.080 Why?
Uterine Neoplasms1201714240.080 Why?
Phosphoproteins1201724510.080 Why?
Chemotherapy, Adjuvant1201635560.070 Why?
T-Lymphocytes22023102660.070 Why?
Disease-Free Survival1201768470.070 Why?
Adaptor Proteins, Signal Transducing1201729090.070 Why?
Macrophages1202157990.070 Why?
Neovascularization, Pathologic1201626310.070 Why?
Aspirin1201631350.060 Why?
Databases, Factual1202080800.060 Why?
HLA-A Antigens120242230.050 Why?
Mice32021820290.050 Why?
Antibodies, Monoclonal1202092630.050 Why?
Cross-Sectional Studies12024263790.050 Why?
Cohort Studies12024417540.050 Why?
Survival Rate12015128400.040 Why?
Myeloablative Agonists120212100.040 Why?
Prospective Studies22023549260.040 Why?
Toll-Like Receptor 4120235880.040 Why?
Animals420211692460.040 Why?
Gene Expression Profiling1201595380.040 Why?
Tumor Microenvironment2202239480.040 Why?
CD4 Lymphocyte Count1202425960.040 Why?
HIV Infections12024175690.040 Why?
Cell Line, Tumor32021171400.040 Why?
Cytotoxicity, Immunologic1202113530.040 Why?
Coculture Techniques1202113400.030 Why?
Thromboxanes12016450.030 Why?
Inhibitory Concentration 50120174640.030 Why?
Antibiotics, Antineoplastic120206810.030 Why?
Risk Factors22021749440.030 Why?
Immunity1202210030.030 Why?
Cyclophosphamide1202122270.030 Why?
Clinical Trials, Phase I as Topic120163300.030 Why?
United States12023730390.030 Why?
Retreatment120165980.030 Why?
Immunologic Memory1202113770.030 Why?
Transplantation Conditioning1202116010.030 Why?
Giant Cell Tumor of Bone120151190.030 Why?
Disease Susceptibility1202017930.030 Why?
Antineoplastic Agents, Phytogenic120176220.030 Why?
Necrosis1201716160.030 Why?
Immunoenzyme Techniques1201517030.030 Why?
Proto-Oncogene Proteins c-kit120167250.030 Why?
Fatal Outcome1201618360.020 Why?
Tumor Burden1201719060.020 Why?
Neoadjuvant Therapy1202229070.020 Why?
Protein Kinase Inhibitors2201757030.020 Why?
Paclitaxel1201717330.020 Why?
Combined Modality Therapy1202085420.020 Why?
Pilot Projects1202187410.020 Why?
Infant22021365350.020 Why?
Child, Preschool22021426690.020 Why?
Neoplasm Staging12020112440.020 Why?
Dose-Response Relationship, Drug12016107600.010 Why?
Cell Differentiation12021116690.010 Why?
Proteomics1201539120.010 Why?
Infant, Newborn12021264220.010 Why?
Disease Progression12016136710.010 Why?
Time Factors12021402180.010 Why?
Genetic Predisposition to Disease12020180650.010 Why?
Positron-Emission Tomography1201566690.010 Why?
Transcription Factors12017121680.010 Why?
Disease Models, Animal12016183490.010 Why?
Risk Assessment12017243150.010 Why?
Mutation12020302380.010 Why?
Tomography, X-Ray Computed12015207600.010 Why?
Wagner's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (167)
Explore
_
Co-Authors (8)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.